Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/32552
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVERBRUGGE, Frederik-
dc.contributor.authorBorlaug, Barry A.-
dc.date.accessioned2020-10-29T08:42:37Z-
dc.date.available2020-10-29T08:42:37Z-
dc.date.issued2020-
dc.date.submitted2020-10-26T15:12:24Z-
dc.identifier.citationJOURNAL OF THE AMERICAN HEART ASSOCIATION, 9 (13) (Art N° e017292)-
dc.identifier.urihttp://hdl.handle.net/1942/32552-
dc.description.sponsorshipDr Verbrugge is supported by a Fellowship of the Belgian American Educational Foundation and by the Special Research Fund (BOF) of Hasselt University (BOF19PD04). Dr Borlaug is supported by R01 HL128526, from the National Institutes of Health.-
dc.language.isoen-
dc.publisherWILEY-
dc.rights© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. JAHA is available at: www.ahajournals.org/journal/jaha-
dc.subject.otherEditorials-
dc.subject.otherangiotensin receptor-neprilysin inhibitor-
dc.subject.otherright ventricle-pulmonary arterial coupling-
dc.titleGetting the “Right” Perspective on Angiotensin Receptor–Neprilysin Inhibition in Heart Failure-
dc.typeJournal Contribution-
dc.identifier.issue13-
dc.identifier.volume9-
local.format.pages4-
local.bibliographicCitation.jcatA2-
dc.description.notesBorlaug, BA (corresponding author), Mayo Clin & Mayo Fdn, 200 First St SW, Rochester, MN 55905 USA.-
dc.description.notesborlaug.barry@mayo.edu-
dc.description.otherBorlaug, BA (corresponding author), Mayo Clin & Mayo Fdn, 200 First St SW, Rochester, MN 55905 USA. borlaug.barry@mayo.edu-
local.publisher.place111 RIVER ST, HOBOKEN 07030-5774, NJ USA-
local.type.refereedRefereed-
local.type.specifiedEditorial Material-
local.bibliographicCitation.artnre017292-
dc.identifier.doi10.1161/JAHA.120.017292-
dc.identifier.pmid32552147-
dc.identifier.isiWOS:000550988200036-
dc.contributor.orcidVerbrugge, Frederik Hendrik/0000-0003-0599-9290; Borlaug,-
dc.contributor.orcidBarry/0000-0001-9375-0596-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Verbrugge, Frederik H.; Borlaug, Barry A.] Hasselt Univ, Dept Cardiovasc Dis, Hasselt, Belgium.-
local.description.affiliation[Verbrugge, Frederik H.] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Hasselt, Belgium.-
item.contributorVERBRUGGE, Frederik-
item.contributorBorlaug, Barry A.-
item.accessRightsOpen Access-
item.fullcitationVERBRUGGE, Frederik & Borlaug, Barry A. (2020) Getting the “Right” Perspective on Angiotensin Receptor–Neprilysin Inhibition in Heart Failure. In: JOURNAL OF THE AMERICAN HEART ASSOCIATION, 9 (13) (Art N° e017292).-
item.fulltextWith Fulltext-
crisitem.journal.eissn2047-9980-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
verbrugge.pdfPublished version321.23 kBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

1
checked on Apr 30, 2024

Page view(s)

30
checked on Sep 7, 2022

Download(s)

4
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.